Oclassen Condylox Claim Of Faster Clearance Cited In FDA Warning Letter

Oclassen Pharmaceuticals' promotional claim that Condylox Gel (podofilox) has faster clearance in the treatment of anogenital warts than 3M's Aldara Cream (imiquimod) has prompted a warning letter from FDA for "misleading comparisons."

More from Archive

More from Pink Sheet